CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
The macrophage checkpoint inhibitor 5F9 combined with rituximab showed promising activity in patients with aggressive and indolent lymphoma. No clinically significant safety eve...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,052
- Institution
- Menlo School
External Links
Identifiers
- ORCID
- 0000-0002-5814-0984
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.